These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Long-term effects of multiple intravitreal antivascular endothelial growth factor injections on intraocular pressure. Kim YJ; Sung KR; Lee KS; Joe SG; Lee JY; Kim JG; Yoon YH Am J Ophthalmol; 2014 Jun; 157(6):1266-1271.e1. PubMed ID: 24561173 [TBL] [Abstract][Full Text] [Related]
10. A lack of delayed intraocular pressure elevation in patients treated with intravitreal injection of bevacizumab and ranibizumab. Wehrli SJ; Tawse K; Levin MH; Zaidi A; Pistilli M; Brucker AJ Retina; 2012 Jul; 32(7):1295-301. PubMed ID: 22466465 [TBL] [Abstract][Full Text] [Related]
11. Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting. Vo Kim S; Fajnkuchen F; Sarda V; Qu-Knafo L; Bodaghi B; Giocanti-Aurégan A Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2165-2171. PubMed ID: 28831613 [TBL] [Abstract][Full Text] [Related]
12. Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections. Frenkel MP; Haji SA; Frenkel RE Arch Ophthalmol; 2010 Dec; 128(12):1523-7. PubMed ID: 21149773 [TBL] [Abstract][Full Text] [Related]